Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wassim W Labaki

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Plasma Cathelicidin is Independently Associated with Reduced Lung Function in COPD: Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortRobert M Burkes, Agathe S Ceppe, David J Couper, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2023
Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function ImpairmentWassim W Labaki, Tian Gu, Susan Murray, et al.
Chest|November 21, 2021
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPDCharles R Esther, Wanda K O'Neal, Wayne H Anderson, et al.
JCI Insight|November 16, 2018
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGeneJ Michael Wells, Margaret M Parker, Robert A Oster, et al.
American Journal of Respiratory and Critical Care Medicine|February 14, 2019
Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational StudyGeorge R Washko, Pietro Nardelli, Samuel Y Ash, et al.
Scientific Reports|August 8, 2019
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics studyWassim W Labaki, Tian Gu, Susan Murray, et al.
Respiratory Medicine|June 30, 2018
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohortWassim W Labaki, Meng Xia, Susan Murray, et al.
Respiratory Research|April 27, 2021
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohortWilliam Z Zhang, Katherine L Hoffman, Kristen T Schiffer, et al.
The Lancet. Respiratory Medicine|November 30, 2024
Associations between life-course FEV<sub>1</sub>/FVC trajectories and respiratory symptoms up to middle age: analysis of data from two prospective cohort studiesJennifer L Perret, Dinh S Bui, Carrie Pistenmaa, et al.
Chest|April 23, 2025
Lung Quantitative CT Scan Textures Are Associated With Systemic Inflammation and Mortality in COPDHira A Awan, Muhammad F A Chaudhary, Anthony D El-Sokkary, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Plasma Cathelicidin is Independently Associated with Reduced Lung Function in COPD: Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortRobert M Burkes, Agathe S Ceppe, David J Couper, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2023
Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function ImpairmentWassim W Labaki, Tian Gu, Susan Murray, et al.
Chest|November 21, 2021
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPDCharles R Esther, Wanda K O'Neal, Wayne H Anderson, et al.
JCI Insight|November 16, 2018
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGeneJ Michael Wells, Margaret M Parker, Robert A Oster, et al.
American Journal of Respiratory and Critical Care Medicine|February 14, 2019
Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational StudyGeorge R Washko, Pietro Nardelli, Samuel Y Ash, et al.
Scientific Reports|August 8, 2019
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics studyWassim W Labaki, Tian Gu, Susan Murray, et al.
Respiratory Medicine|June 30, 2018
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohortWassim W Labaki, Meng Xia, Susan Murray, et al.
Respiratory Research|April 27, 2021
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohortWilliam Z Zhang, Katherine L Hoffman, Kristen T Schiffer, et al.
The Lancet. Respiratory Medicine|November 30, 2024
Associations between life-course FEV<sub>1</sub>/FVC trajectories and respiratory symptoms up to middle age: analysis of data from two prospective cohort studiesJennifer L Perret, Dinh S Bui, Carrie Pistenmaa, et al.
Chest|April 23, 2025
Lung Quantitative CT Scan Textures Are Associated With Systemic Inflammation and Mortality in COPDHira A Awan, Muhammad F A Chaudhary, Anthony D El-Sokkary, et al.
Pageof 10